We explored the theorized upregulation of platelet-activating factor ( PAF ) - mediated biologic responses following lipoprotein-associated phospholipase A@ ( Lp-PLA@ ) inhibition using human platelet aggregation studies in an in vitro experiment and in @ clinical trials .